200 related articles for article (PubMed ID: 34228639)
1. Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity.
Sáez-Orellana F; Leroy T; Ribeiro F; Kreis A; Leroy K; Lalloyer F; Baugé E; Staels B; Duyckaerts C; Brion JP; Gailly P; Octave JN; Pierrot N
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34228639
[TBL] [Abstract][Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
3. The upside of APP at synapses.
Hoe HS; Lee HK; Pak DT
CNS Neurosci Ther; 2012 Jan; 18(1):47-56. PubMed ID: 21199446
[TBL] [Abstract][Full Text] [Related]
4. L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang Y; Huang LJ; Shi S; Xu SF; Wang XL; Peng Y
CNS Neurosci Ther; 2016 Dec; 22(12):979-987. PubMed ID: 27439966
[TBL] [Abstract][Full Text] [Related]
5. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
Ducheix S; Podechard N; Lasserre F; Polizzi A; Pommier A; Murzilli S; Di Lisio C; D'Amore S; Bertrand-Michel J; Montagner A; Pineau T; Loiseau N; Lobaccaro JM; Martin PG; Guillou H
Biochimie; 2013 Mar; 95(3):556-67. PubMed ID: 23063693
[TBL] [Abstract][Full Text] [Related]
6. The role of synthetic ligand of PPARα in regulation of transcription of genes related to mitochondria biogenesis and dynamic in an animal model of Alzheimer's disease.
Żulińska S; Strosznajder AK; Strosznajder JB
Folia Neuropathol; 2023; 61(2):138-143. PubMed ID: 37587888
[TBL] [Abstract][Full Text] [Related]
7. Huntingtin associated protein 1 regulates trafficking of the amyloid precursor protein and modulates amyloid beta levels in neurons.
Yang GZ; Yang M; Lim Y; Lu JJ; Wang TH; Qi JG; Zhong JH; Zhou XF
J Neurochem; 2012 Sep; 122(5):1010-22. PubMed ID: 22731248
[TBL] [Abstract][Full Text] [Related]
8. Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice.
Dickey CA; Loring JF; Montgomery J; Gordon MN; Eastman PS; Morgan D
J Neurosci; 2003 Jun; 23(12):5219-26. PubMed ID: 12832546
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate reduces amyloidogenic processing of APP in APP/PS1 transgenic mice via PPAR-α/PI3-K pathway.
Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y
Int J Dev Neurosci; 2014 Nov; 38():223-31. PubMed ID: 25447788
[TBL] [Abstract][Full Text] [Related]
10. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
11. Intracellular amyloid precursor protein sorting and amyloid-β secretion are regulated by Src-mediated phosphorylation of Mint2.
Chaufty J; Sullivan SE; Ho A
J Neurosci; 2012 Jul; 32(28):9613-25. PubMed ID: 22787047
[TBL] [Abstract][Full Text] [Related]
12. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Modulates ubc9 Expression and Synaptic Redistribution in the Brain of APP/PS1 Mice and Cortical Neurons.
Lai YJ; Liu L; Hu XT; He L; Chen GJ
J Mol Neurosci; 2017 Mar; 61(3):436-448. PubMed ID: 28150190
[TBL] [Abstract][Full Text] [Related]
14. FAD-mutation of APP is associated with a loss of its synaptotrophic activity.
Seeger G; Gärtner U; Ueberham U; Rohn S; Arendt T
Neurobiol Dis; 2009 Aug; 35(2):258-63. PubMed ID: 19450683
[TBL] [Abstract][Full Text] [Related]
15. The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model.
Wu Y; Whittaker HT; Noy S; Cleverley K; Brault V; Herault Y; Fisher EMC; Wiseman FK
PLoS One; 2021; 16(7):e0242236. PubMed ID: 34292972
[TBL] [Abstract][Full Text] [Related]
16. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.
Almeida CG; Tampellini D; Takahashi RH; Greengard P; Lin MT; Snyder EM; Gouras GK
Neurobiol Dis; 2005 Nov; 20(2):187-98. PubMed ID: 16242627
[TBL] [Abstract][Full Text] [Related]
17. The Association of Amyloid-β Protein Precursor With α- and β-Secretases in Mouse Cerebral Cortex Synapses Is Altered in Early Alzheimer's Disease.
Pliássova A; Lopes JP; Lemos C; Oliveira CR; Cunha RA; Agostinho P
Mol Neurobiol; 2016 Oct; 53(8):5710-21. PubMed ID: 26497029
[TBL] [Abstract][Full Text] [Related]
18. beta-Amyloid disrupts activity-dependent gene transcription required for memory through the CREB coactivator CRTC1.
España J; Valero J; Miñano-Molina AJ; Masgrau R; Martín E; Guardia-Laguarta C; Lleó A; Giménez-Llort L; Rodríguez-Alvarez J; Saura CA
J Neurosci; 2010 Jul; 30(28):9402-10. PubMed ID: 20631169
[TBL] [Abstract][Full Text] [Related]
19. Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.
Kumar S; Reddy AP; Yin X; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2428-2440. PubMed ID: 31181293
[TBL] [Abstract][Full Text] [Related]
20. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
